Sangamo BioSciences (SGMO): Q2 EPS of -$0.10 beats by $0.02. Revenue of $6.9M beats by $2.13M....

|About: Sangamo Therapeutics, Inc. (SGMO)|By:, SA News Editor
Sangamo BioSciences (SGMO): Q2 EPS of -$0.10 beats by $0.02. Revenue of $6.9M beats by $2.13M. Shares +1.2% AH. (PR)